230 related articles for article (PubMed ID: 23912600)
1. DNA vaccines: a simple DNA sensing matter?
Coban C; Kobiyama K; Jounai N; Tozuka M; Ishii KJ
Hum Vaccin Immunother; 2013 Oct; 9(10):2216-21. PubMed ID: 23912600
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies to improve DNA vaccine immunogenicity.
Coban C; Kobiyama K; Aoshi T; Takeshita F; Horii T; Akira S; Ishii KJ
Curr Gene Ther; 2011 Dec; 11(6):479-84. PubMed ID: 22023477
[TBL] [Abstract][Full Text] [Related]
3. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
[TBL] [Abstract][Full Text] [Related]
4. Immune sensing of DNA and strategies for fish DNA vaccine development.
Chang CJ
Fish Shellfish Immunol; 2020 Jun; 101():252-260. PubMed ID: 32247047
[TBL] [Abstract][Full Text] [Related]
5. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.
Lladser A; Mougiakakos D; Tufvesson H; Ligtenberg MA; Quest AF; Kiessling R; Ljungberg K
Mol Ther; 2011 Mar; 19(3):594-601. PubMed ID: 21157438
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular mechanisms of DNA vaccines.
Coban C; Koyama S; Takeshita F; Akira S; Ishii KJ
Hum Vaccin; 2008; 4(6):453-6. PubMed ID: 18535407
[TBL] [Abstract][Full Text] [Related]
7. Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.
Kobiyama K; Jounai N; Aoshi T; Tozuka M; Takeshita F; Coban C; Ishii KJ
Vaccines (Basel); 2013 Jul; 1(3):278-92. PubMed ID: 26344113
[TBL] [Abstract][Full Text] [Related]
8. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
9. Harnessing DNA-induced immune responses for improving cancer vaccines.
Herrada AA; Rojas-Colonelli N; González-Figueroa P; Roco J; Oyarce C; Ligtenberg MA; Lladser A
Hum Vaccin Immunother; 2012 Nov; 8(11):1682-93. PubMed ID: 23111166
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
Iurescia S; Fioretti D; Rinaldi M
Front Immunol; 2018; 9():711. PubMed ID: 29686682
[TBL] [Abstract][Full Text] [Related]
11. Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.
Garrod T; Grubor-Bauk B; Yu S; Gargett T; Gowans EJ
Hum Vaccin Immunother; 2014; 10(9):2679-83. PubMed ID: 25483501
[TBL] [Abstract][Full Text] [Related]
12. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
13. A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.
Suschak JJ; Wang S; Fitzgerald KA; Lu S
J Immunol; 2016 Jan; 196(1):310-6. PubMed ID: 26590319
[TBL] [Abstract][Full Text] [Related]
14. Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.
Rose AH; Hoffmann FW; Hara JH; Urschitz J; Moisyadi S; Hoffmann PR; Bertino P
Hum Vaccin Immunother; 2015; 11(9):2305-11. PubMed ID: 26091088
[TBL] [Abstract][Full Text] [Related]
15. Molecular Adjuvants for DNA Vaccines: Application, Design, Preparation, and Formulation.
Sabbaghi A; Ghaemi A
Methods Mol Biol; 2021; 2197():87-112. PubMed ID: 32827133
[TBL] [Abstract][Full Text] [Related]
16. Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
Leitner WW; Bergmann-Leitner ES; Hwang LN; Restifo NP
Vaccine; 2006 Jun; 24(24):5110-8. PubMed ID: 16725231
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
Colluru VT; McNeel DG
Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
[TBL] [Abstract][Full Text] [Related]
18. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells.
Muthumani G; Laddy DJ; Sundaram SG; Fagone P; Shedlock DJ; Kannan S; Wu L; Chung CW; Lankaraman KM; Burns J; Muthumani K; Weiner DB
Immunology; 2009 Sep; 128(1 Suppl):e612-20. PubMed ID: 19740322
[TBL] [Abstract][Full Text] [Related]
19. B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA.
Rastogi I; McNeel DG
Oncoimmunology; 2023; 12(1):2212550. PubMed ID: 37205983
[TBL] [Abstract][Full Text] [Related]
20. Modulating APOBEC expression enhances DNA vaccine immunogenicity.
Almeida RR; Raposo RA; Coirada FC; da Silva JR; de Souza Ferreira LC; Kalil J; Nixon DF; Cunha-Neto E
Immunol Cell Biol; 2015 Nov; 93(10):868-76. PubMed ID: 25953029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
